Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
OSBPL6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CCR10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYRK4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
F11R - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DIS3L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AGAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITGA8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AREL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEX26 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CRKL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SULF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MST1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HDAC9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AQR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DPP8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VWA9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRT18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KDELR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP9A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on